AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Palo Alto’s $25 billion CyberArk deal was worth $21 billion at closing. The shares are now worth $37 billion
2
From stealth to a $500 million valuation: Former Microsoft engineers raise $70 million to challenge data giants
3
Former Unit 8200 officers raise $50 million in just nine months for AI security startup
4
Israeli company unveils new surveillance drone as it targets production of 1,000 units a year
5
ServiceNow lays off more employees as its shares fall 35% in under two weeks
More news

Glaucoma

4 stories about Glaucoma
מיכאל בלקין מוסף

The 83-year-old who sold his invention for $466 million, and still walks to work every morning

14.08.25|Roni Dori
Michael Belkin’s journey from rooftop experiments to global glaucoma breakthroughs proves some minds never retire.
דריה להמן-בלומנטל

The Israeli startup treating the silent thief of sight

30.01.22|Yafit Ovadia
BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness
דריה למאן בלומנטל מנכ״ל ארגון בלקין לייזר

Belkin Laser announces $12.2 million raised in series B funding

21.07.20|Hagar Ravet
The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years
BioLight ביולייט איי אופטימה IOPtima

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima

21.11.17|Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange